Coronary Artery Disease and Myocardial Infarction
Nicolas M Van Mieghem, Joost Daemen,
Pamela S Douglas, Harriette Van Spall,
Gurleen Kaur, Michelle O'Donoghue,
Aruna D Pradhan, Gurleen Kaur,
Yassir Javaid, , , et al
Media
Gurleen Kaur, Michelle O'Donoghue,
Aruna D Pradhan, Gurleen Kaur,
Yassir Javaid, , , et al
Media
Nicolas M Van Mieghem, Joost Daemen,
Pamela S Douglas, Harriette Van Spall,
Gurleen Kaur, Michelle O'Donoghue,
Aruna D Pradhan, Gurleen Kaur,
Yassir Javaid, , , et al
Articles
Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?
Citation:
US Cardiology Review 2017; 11(1):37–8
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
- Views:
485
- Downloads:
2
Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy
Citation:
US Cardiology Review 2017;11(1):31–6
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
- Views:
4289
- Downloads:
7
- Citations: 1
What the Cardiologist Needs to Know About Medications for Type 2 Diabetes
Citation:
US Cardiology Review 2016;10(2):54–9
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
- Views:
1388
- Downloads:
5
Pharmacologic Strategies for Management of Pulmonary Arterial Hypertension
Citation:
US Cardiology Review 2016;10(2):78–84
- Abstract
- Full text
- Login or register to view PDF.
- Permissions
- References
- Views:
2212
- Downloads:
17